Study of Bile Acids in Patients With Peroxisomal Disorders
Terminated
Children's Hospital Medical Center, Cincinnati
N/A
1969-12-31
OBJECTIVES: I. Determine the effectiveness of oral bile acid therapy with cholic acid,
chenodeoxycholic acid, and ursodeoxycholic acid in patients with peroxisomal disorders
involving impaired primary bile acid synthesis.
II. Determine whether suppression of synthesis of atypical bile acids and enrichment of bile
acid pool with this regimen is effective in treating this patient population and improving
quality of life.
Study of Bile Acids in Patients With Peroxisomal Disorders
Terminated
University of Cincinnati
N/A
1969-12-31
OBJECTIVES: I. Determine the effectiveness of oral bile acid therapy with cholic acid,
chenodeoxycholic acid, and ursodeoxycholic acid in patients with peroxisomal disorders
involving impaired primary bile acid synthesis.
II. Determine whether suppression of synthesis of atypical bile acids and enrichment of bile
acid pool with this regimen is effective in treating this patient population and improving
quality of life.
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Completed
Children's Hospital Medical Center, Cincinnati
Phase 3
1992-01-01
OBJECTIVES:
I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate
treatment to patients with identified inborn errors of bile acid synthesis and metabolism
II. To assess the safety and tolerability of cholic acid
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
Completed
Retrophin, Inc.
Phase 3
1992-01-01
OBJECTIVES:
I. To Evaluate the therapeutic efficacy of cholic acid during provision of compassionate
treatment to patients with identified inborn errors of bile acid synthesis and metabolism
II. To assess the safety and tolerability of cholic acid
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
